Cargando…

Chlormadinone acetate is effective for hot flush during androgen deprivation therapy

PURPOSE: To investigate the clinical efficacy of low-dose chlormadinone acetate (CMA) in prostate cancer patients who suffer from hot flushes that is a major side effect of androgen deprivation therapy. METHODS: Our study included 32 prostate cancer patients who had severe hot flush after undergoing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koike, Hidekazu, Morikawa, Yasuyuki, Matsui, Hiroshi, Shibata, Yasuhiro, Ito, Kazuto, Suzuki, Kazuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Pacific Prostate Society (APPS) 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814123/ https://www.ncbi.nlm.nih.gov/pubmed/24223412 http://dx.doi.org/10.12954/PI.12010

Ejemplares similares

Simple method for preventing inguinal hernias after radical retropubic prostatectomy
por: Koike, Hidekazu, et al.
Publicado: (2013)

Androgen receptor coactivator p120 subtype β is highly expressed in prostate cancer
por: Muramatsu, Kazumichi, et al.
Publicado: (2013)

Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer
por: Sekine, Yoshitaka, et al.
Publicado: (2021)

Ethinylestradiol/Chlormadinone Acetate: Dermatological Benefits
por: Guerra-Tapia, Aurora, et al.
Publicado: (2012)

Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
por: Vázquez, Mercedes Gómez, et al.
Publicado: (2012)

Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels
por: Okamoto, Kohei, et al.
Publicado: (2015)

A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
por: Miyazawa, Yoshiyuki, et al.
Publicado: (2017)

SUN-234 Brain-Selective Estrogen Therapy to Prevent Androgen Deprivation Therapy-Related Hot Flushes
por: Merchenthaler, Istvan, et al.
Publicado: (2020)

Brain-Selective Estrogen Therapy Prevents Androgen Deprivation-Associated Hot Flushes in a Rat Model
por: Merchenthaler, Istvan, et al.
Publicado: (2020)

Clinical utility of chlormadinone acetate (Lutoral™) in frozen‐thawed embryo transfer with hormone replacement
por: Asada, Yoshimasa, et al.
Publicado: (2019)

The effect of chlormadinone acetate on odontogenic differentiation of human dental pulp cells: in vitro study
por: Kim, Se-Min, et al.
Publicado: (2017)

Chlormadinone acetate in progestin‐primed ovarian stimulation does not negatively affect clinical results
por: Shibasaki, Sena, et al.
Publicado: (2023)

Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study
por: Zimmerman, Yvette, et al.
Publicado: (2022)

The Effects of Chlormadinone Acetate on Lower Urinary Tract Symptoms and Erectile Functions of Patients with Benign Prostatic Hyperplasia: A Prospective Multicenter Clinical Study
por: Fujimoto, Kiyohide, et al.
Publicado: (2013)

Combined oral contraceptives containing chlormadinone acetate and breast cancer: results of a case-control study.
por: Ebeling, K., et al.
Publicado: (1991)

Hot flushes, hypertension and haemodialysis
por: de Zoysa, Janak R., et al.
Publicado: (2011)

Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist
por: Miyazawa, Yoshiyuki, et al.
Publicado: (2015)

Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
por: Podfigurna, A., et al.
Publicado: (2019)

A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial
por: Jaisamrarn, Unnop, et al.
Publicado: (2018)

Hot flushes and quality of life during menopause
por: Luoto, Riitta
Publicado: (2009)

CGRP Is Critical for Hot Flushes in Ovariectomized Mice
por: Wilhelms, Daniel B., et al.
Publicado: (2019)

The pharmacological and hormonal therapy of hot flushes in breast cancer survivors
por: Wiśniewska, Iwona, et al.
Publicado: (2015)

Androgen deprivation induces phenotypic plasticity and promotes resistance to molecular targeted therapy in a PTEN-deficient mouse model of prostate cancer
por: De Velasco, Marco A., et al.
Publicado: (2014)

Neurokinin B Administration Induces Hot Flushes in Women
por: Jayasena, Channa N., et al.
Publicado: (2015)

A multicentre randomised controlled trial of a guided self-help cognitive behavioural therapy to MANage the impact of hot flushes and night sweats in patients with prostate CANcer undergoing androgen deprivation therapy (MANCAN2)
por: Crabb, Simon, et al.
Publicado: (2023)

Treating hot flushes with a neurokinin 3 receptor antagonist
por: Prague, Julia K., et al.
Publicado: (2017)

Buspirone Nanovesicular Nasal System for Non-Hormonal Hot Flushes Treatment
por: Touitou, Elka, et al.
Publicado: (2018)

Androgen deprivation therapy prevents bladder cancer recurrence
por: Izumi, Koji, et al.
Publicado: (2014)

Effects of Aqueous Extracts of Cynanchum wilfordii in Rat Models for Postmenopausal Hot Flush
por: Lee, Gyuok, et al.
Publicado: (2016)

Open-label placebos for menopausal hot flushes: a randomized controlled trial
por: Pan, Yiqi, et al.
Publicado: (2020)

Analysis of the circulating myeloid‐derived suppressor cells during androgen deprivation therapy for prostate cancer
por: Kohada, Yuki, et al.
Publicado: (2021)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer
por: Sato, Yuzuri Tsurumaki, et al.
Publicado: (2014)

Starting and stopping menopausal hormone therapy and antidepressants for hot flushes: A case-based approach
por: Athanasiadis, Loukas, et al.
Publicado: (2019)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)

Flush
por: Woolf, Virginia, 1882-1941
Publicado: (1956)

Cannot write session to /tmp/vufind_sessions/sess_d53se3acn83u96tmd9cok9dbk6